Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)
CNY 10.57
(-1.03%)
CNY 10.57
(-1.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.18 Billion | 1.02 Billion | 945.79 Million | 1.33 Billion | 2.1 Billion | 2.17 Billion |
| Cost of Revenue | 475.55 Million | 365.57 Million | 309.38 Million | 491.3 Million | 509.92 Million | 351.96 Million |
| Gross Profit | 711.23 Million | 662.84 Million | 636.41 Million | 847.58 Million | 1.59 Billion | 1.82 Billion |
| Operating Expenses | 631.38 Million | 679.55 Million | 765.23 Million | 786.47 Million | 1.38 Billion | 1.6 Billion |
| Selling, General and Administrative Expenses | 458.46 Million | 479.76 Million | 618.76 Million | 685.58 Million | 1.24 Billion | 1.45 Billion |
| Research and Development Expenses | 112.8 Million | 89.26 Million | 99.92 Million | 112.01 Million | 112.44 Million | 79 Million |
| Other Expenses | 4.32 Million | 110.51 Million | 46.54 Million | -11.13 Million | 27.15 Million | -1.89 Million |
| Cost and Expenses | 1.1 Billion | 1.04 Billion | 1.07 Billion | 1.27 Billion | 1.89 Billion | 1.95 Billion |
| Operating Income | 79.02 Million | 57.6 Million | 454.8 Million | 84.21 Million | 228.8 Million | 250.99 Million |
| Interest Expense | 22.89 Million | 22.62 Million | 13.8 Million | 9.32 Million | 6.49 Million | 1.97 Million |
| Income Tax Expense | 11.29 Million | 13.56 Million | 103.17 Million | 6.52 Million | 54.36 Million | 44.71 Million |
| Earnings before Tax | 81.37 Million | 40.06 Million | 452.85 Million | 33.15 Million | 228.22 Million | 249.09 Million |
| Net Income | 73.66 Million | 30.2 Million | 350.95 Million | 29.32 Million | 177.18 Million | 205.81 Million |
| Earnings Per Share Basic | 0.24 | 0.10 | 1.13 | 0.09 | 0.57 | 0.65 |
| Earnings Per Share Diluted | 0.24 | 0.10 | 1.13 | 0.09 | 0.57 | 0.65 |
| Weighted Average Shares Outstanding | 306.92 Million | 316.6 Million | 309.78 Million | 309.78 Million | 310.84 Million | 316.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 306.92 Million | 316.6 Million | 309.78 Million | 309.78 Million | 310.84 Million | 316.63 Million |
| Gross Margin | 0.60 | 0.64 | 0.67 | 0.63 | 0.76 | 0.84 |
| EBIT Margin | 0.15 | 0.16 | 0.61 | 0.12 | 0.14 | 0.15 |
| Profit Margin | 0.06 | 0.03 | 0.37 | 0.02 | 0.08 | 0.09 |
| EBITDA | 183.66 Million | 131.6 Million | 540.61 Million | 122.43 Million | 321.05 Million | 324.87 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.48 | 0.06 | 0.11 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 315.08 Million | 273.79 Million | 243.78 Million | 264.32 Million | 1.18 Billion | 285.23 Million |
| Cost of Revenue | 169.73 Million | 144.28 Million | 105.98 Million | 129.16 Million | 476.38 Million | 124.71 Million |
| Gross Profit | 145.34 Million | 129.51 Million | 137.8 Million | 135.15 Million | 710.4 Million | 160.51 Million |
| Operating Expenses | 132.18 Million | 123.86 Million | 144.94 Million | 133.42 Million | 693.35 Million | 164.01 Million |
| Selling, General and Administrative Expenses | 171.63 Million | 102.12 Million | 119.93 Million | -28.17 Million | - | 161.19 Million |
| Research and Development Expenses | 27.37 Million | 20.94 Million | 24.69 Million | 35.04 Million | - | 25.88 Million |
| Other Expenses | -66.83 Million | -797.19 Thousand | -318.3 Thousand | 1.5 Million | 2.35 Million | -87.87 Thousand |
| Cost and Expenses | 301.91 Million | 268.14 Million | 250.92 Million | 262.59 Million | 1.16 Billion | 288.73 Million |
| Operating Income | 18.05 Million | 5.64 Million | -7.14 Million | 16.28 Million | 79.02 Million | 6.26 Million |
| Interest Expense | 7.63 Million | 8.1 Million | 6.94 Million | 5.89 Million | 22.89 Million | 5.77 Million |
| Income Tax Expense | 4.72 Million | -4.2 Million | 1.71 Million | 5.16 Million | 11.29 Million | -816.02 Thousand |
| Earnings before Tax | 18.2 Million | -5.79 Million | 12.3 Million | 17.78 Million | 81.37 Million | 6.21 Million |
| Net Income | 14.31 Million | 7.48 Million | 18.78 Million | 13.53 Million | 73.66 Million | 7.93 Million |
| Earnings Per Share Basic | 0.05 | 0.02 | 0.06 | 0.07 | - | 0.03 |
| Earnings Per Share Diluted | 0.05 | 0.02 | 0.06 | 0.07 | - | 0.03 |
| Weighted Average Shares Outstanding | 286.23 Million | 316.39 Million | 316.39 Million | 306.87 Million | 306.92 Million | 309.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 286.23 Million | 316.39 Million | 316.39 Million | 306.87 Million | 306.92 Million | 309.82 Million |
| Gross Margin | 0.46 | 0.47 | 0.57 | 0.51 | 0.60 | 0.56 |
| EBIT Margin | 0.08 | 0.13 | 0.09 | 0.07 | - | 0.04 |
| Profit Margin | 0.05 | 0.03 | 0.08 | 0.05 | 0.06 | 0.03 |
| EBITDA | 25.84 Million | 34.35 Million | 22.55 Million | 18.61 Million | - | 11.89 Million |
| Earnings Before Tax Margin | 0.06 | 0.02 | -0.03 | 0.06 | 0.07 | 0.02 |
HAG
STI
BZYR
1860
TISCY
BSM